{"id":749899,"date":"2023-04-20T17:44:55","date_gmt":"2023-04-20T21:44:55","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/"},"modified":"2023-04-20T17:44:55","modified_gmt":"2023-04-20T21:44:55","slug":"meiragtx-to-participate-in-upcoming-investor-conferences-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/","title":{"rendered":"MeiraGTx to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">LONDON and NEW YORK, April  20, 2023  (GLOBE NEWSWIRE) &#8212; MeiraGTx Holdings\u00a0plc\u00a0(NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., President and Chief Executive Officer, will participate in the following investor conferences:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">\n          <strong>Chardan&#8217;s Virtual 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit<\/strong><br \/>\n          \n        <\/li>\n<\/ul>\n<p>Corporate presentation: Monday, April 24, 2023, at 2:30 p.m. ET<\/p>\n<p>Panel Discussion: \u201c<strong><em>Gene Therapy: Positioning for CMC Success at Every Stage<\/em><\/strong><em>\u201d <\/em>\u2013<\/p>\n<p>Tuesday, April 25, 2023, at 12:00 p.m. ET<\/p>\n<ul type=\"disc\">\n<li>\u00a0<strong>BofA Securities 2023 Healthcare Conference<\/strong><\/li>\n<\/ul>\n<p>Corporate Presentation: Wednesday, May 10, 2023, at 2:35 p.m. PT<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">\n          <strong>RBC Capital Markets 2023 Global Healthcare Conference<\/strong><br \/>\n          \n        <\/li>\n<\/ul>\n<p>Corporate Presentation: Wednesday, May 17, 2023, at 10:00 a.m. ET<\/p>\n<p>A live webcast of the corporate presentations will be available on the Investors page of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=X5MxtWPTfXSGq9Hz9ssjHjPRMVpyovKBYxkh-vF5fy4KEsamLYCHdb52ojJbKfoEQhMlcfI-A4VKq5bd6g5lq0U4KhEdWkO-Qq32J68Llw2p1iJdEb4K33NtPd4sSjMkVI2fLZ2sy3hVPCAj6b--8Q==\" rel=\"nofollow noopener\" target=\"_blank\">www.investors.meiragtx.com<\/a>. Replays will be available for approximately 30 days following the presentation dates.<\/p>\n<p>\n        <strong>About MeiraGTx<\/strong>\n      <\/p>\n<p>MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs. MeiraGTx has core capabilities in viral vector design and optimization and gene therapy manufacturing, and a transformative gene regulation platform technology that allows precise, dose responsive control of gene expression by oral small molecules with dynamic range that can exceed 5000-fold. Led by an experienced management team, MeiraGTx has taken a portfolio approach by licensing, acquiring, and developing technologies that give depth across both product candidates and indications. MeiraGTx\u2019s initial focus is on three distinct areas of unmet medical need: ocular, including both inherited retinal diseases as well as large degenerative ocular diseases, neurodegenerative diseases and severe forms of xerostomia. Though initially focusing on the eye, central nervous system, and salivary gland, MeiraGTx plans to expand its focus to develop additional gene therapy treatments for patients suffering from a range of serious diseases.<\/p>\n<p>For more information, please visit www.meiragtx.com.<\/p>\n<p>\n        <strong>Contacts<\/strong><\/p>\n<p>        <strong>Investors:<\/strong><br \/>\n        <br \/>MeiraGTx<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=K0Nygfqql1hPv00gBX-PJUuAbdsQQbDH3LKnZUcYGfMgwMr5upwrHZ4sRQFedOO82GpbiYoXHrk6rTDvr8KQYQHFeu1eUjV0XG3rJbexPw2FrtXlybYNJdmh2AxS7t0HtotBgrkpeKBDqoRYnlBF42u8qDLdr81xYfC40844MHNbqqHFczJfYcFudA9EkshzwtwzVPN2TmIcRf-X7iyZCX9n4My3dyDKPbFSEJHnpTg-HtwqoAIgCo4-9THVUYgyWMF89lBN7qvFduxsnnC7Jg==\" rel=\"nofollow noopener\" target=\"_blank\">Investors@meiragtx.com<\/a><\/p>\n<p>\n        <strong>Media:<\/strong><br \/>\n        <br \/>Jason Braco, Ph.D.<br \/>LifeSci Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OmmIT0HyBzt-FMHv46UnG6Wqi_aExTQqzoEa0yyQolxU7I-DlwFeuJqvw66ZBvl8mHi2HxqAX76Oi_IdHImsO1TpTg0T7b5vvNnvRaTg_WE=\" rel=\"nofollow noopener\" target=\"_blank\">jbraco@lifescicomms.com<\/a><\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjU3MiM1NTM5MTg3IzIxMDA0MTQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/M2RmMzMzMTctNThkMS00NjIwLWEyOGYtYjU1YWVlNjkzYWFmLTExMTE5ODU=\/tiny\/MeiraGTx.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LONDON and NEW YORK, April 20, 2023 (GLOBE NEWSWIRE) &#8212; MeiraGTx Holdings\u00a0plc\u00a0(NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., President and Chief Executive Officer, will participate in the following investor conferences: Chardan&#8217;s Virtual 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit Corporate presentation: Monday, April 24, 2023, at 2:30 p.m. ET Panel Discussion: \u201cGene Therapy: Positioning for CMC Success at Every Stage\u201d \u2013 Tuesday, April 25, 2023, at 12:00 p.m. ET \u00a0BofA Securities 2023 Healthcare Conference Corporate Presentation: Wednesday, May 10, 2023, at 2:35 p.m. PT RBC Capital Markets 2023 Global Healthcare Conference Corporate Presentation: Wednesday, May 17, 2023, at 10:00 a.m. ET A live webcast of the corporate presentations will be &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MeiraGTx to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-749899","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MeiraGTx to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MeiraGTx to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LONDON and NEW YORK, April 20, 2023 (GLOBE NEWSWIRE) &#8212; MeiraGTx Holdings\u00a0plc\u00a0(NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., President and Chief Executive Officer, will participate in the following investor conferences: Chardan&#8217;s Virtual 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit Corporate presentation: Monday, April 24, 2023, at 2:30 p.m. ET Panel Discussion: \u201cGene Therapy: Positioning for CMC Success at Every Stage\u201d \u2013 Tuesday, April 25, 2023, at 12:00 p.m. ET \u00a0BofA Securities 2023 Healthcare Conference Corporate Presentation: Wednesday, May 10, 2023, at 2:35 p.m. PT RBC Capital Markets 2023 Global Healthcare Conference Corporate Presentation: Wednesday, May 17, 2023, at 10:00 a.m. ET A live webcast of the corporate presentations will be &hellip; Continue reading &quot;MeiraGTx to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-20T21:44:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjU3MiM1NTM5MTg3IzIxMDA0MTQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meiragtx-to-participate-in-upcoming-investor-conferences-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meiragtx-to-participate-in-upcoming-investor-conferences-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MeiraGTx to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2023-04-20T21:44:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meiragtx-to-participate-in-upcoming-investor-conferences-3\\\/\"},\"wordCount\":331,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meiragtx-to-participate-in-upcoming-investor-conferences-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjU3MiM1NTM5MTg3IzIxMDA0MTQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meiragtx-to-participate-in-upcoming-investor-conferences-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meiragtx-to-participate-in-upcoming-investor-conferences-3\\\/\",\"name\":\"MeiraGTx to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meiragtx-to-participate-in-upcoming-investor-conferences-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meiragtx-to-participate-in-upcoming-investor-conferences-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjU3MiM1NTM5MTg3IzIxMDA0MTQ=\",\"datePublished\":\"2023-04-20T21:44:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meiragtx-to-participate-in-upcoming-investor-conferences-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meiragtx-to-participate-in-upcoming-investor-conferences-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meiragtx-to-participate-in-upcoming-investor-conferences-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjU3MiM1NTM5MTg3IzIxMDA0MTQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgxMjU3MiM1NTM5MTg3IzIxMDA0MTQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/meiragtx-to-participate-in-upcoming-investor-conferences-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MeiraGTx to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MeiraGTx to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/","og_locale":"en_US","og_type":"article","og_title":"MeiraGTx to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"LONDON and NEW YORK, April 20, 2023 (GLOBE NEWSWIRE) &#8212; MeiraGTx Holdings\u00a0plc\u00a0(NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., President and Chief Executive Officer, will participate in the following investor conferences: Chardan&#8217;s Virtual 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit Corporate presentation: Monday, April 24, 2023, at 2:30 p.m. ET Panel Discussion: \u201cGene Therapy: Positioning for CMC Success at Every Stage\u201d \u2013 Tuesday, April 25, 2023, at 12:00 p.m. ET \u00a0BofA Securities 2023 Healthcare Conference Corporate Presentation: Wednesday, May 10, 2023, at 2:35 p.m. PT RBC Capital Markets 2023 Global Healthcare Conference Corporate Presentation: Wednesday, May 17, 2023, at 10:00 a.m. ET A live webcast of the corporate presentations will be &hellip; Continue reading \"MeiraGTx to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-20T21:44:55+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjU3MiM1NTM5MTg3IzIxMDA0MTQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MeiraGTx to Participate in Upcoming Investor Conferences","datePublished":"2023-04-20T21:44:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/"},"wordCount":331,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjU3MiM1NTM5MTg3IzIxMDA0MTQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/","name":"MeiraGTx to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjU3MiM1NTM5MTg3IzIxMDA0MTQ=","datePublished":"2023-04-20T21:44:55+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjU3MiM1NTM5MTg3IzIxMDA0MTQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgxMjU3MiM1NTM5MTg3IzIxMDA0MTQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/meiragtx-to-participate-in-upcoming-investor-conferences-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MeiraGTx to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749899","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=749899"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/749899\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=749899"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=749899"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=749899"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}